To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil ® Nasal Spray
Condition: Seasonal Allergic Rhinitis Intervention: Drug: 140/100 μg Azelastine hydrochloride/Beclomethasone Dipropionate) Sponsor: Pharmactive Ilac Sanayi ve Tic A.S. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2021 Category: Research Source Type: clinical trials